NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company†or "MindMed†), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences: Stifel 2025 Healthcare Conference Format: Presentation Date and Time: Wednesday, November 12, 2025 at 1:20 PM ET Location: New York, NY Webcast Link: Stifel 2025 H. ...